Lorenzo De Benedictis

Company: 3CON Technologies

Job title: Head of Business Unit Pharma, Medical

Seminars:

Overcoming RNase-Related Challenges through RNase-free Single-Use Assemblies and Non-Thermal Plasma-Based Inhibition 11:30 am

Pioneering Non-Thermal Plasma Inhibition of RNases as a cutting-edge alternative for ensuring RNase-free single-use bioprocess containers and assemblies when conventional methods fail Elevating mRNA development and manufacturing processes by mitigating the risk of RNase contamination Exploring the inhibition of RNase through ionised air targeted at enzymes, showcasing an innovative approach to safeguarding bioprocess integrityRead more

day: Day Two